Currently out of the existing stock ratings of David Hoang, 65 are a BUY (79.27%), 5 are a SELL (6.1%), 12 are a HOLD (14.63%).

David Hoang

Work Performance Price Targets & Ratings Chart

Analyst David Hoang, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 59.92% that have a potential upside of 33.64% achieved within 224 days.

David Hoang’s has documented 154 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AXSM, Axsome Therapeutics at 29-Sep-2026.

Wall Street Analyst David Hoang

Analyst best performing recommendations are on MLNT (MELINTA THERAPEUTICS).
The best stock recommendation documented was for HRMY (HARMONY BIOSCIENCES HOLDINGS) at 6/30/2026. The price target of $36 was fulfilled within 1 day with a profit of $0.41 (1.13%) receiving and performance score of 11.26.

Average potential price target upside

ORTX Orchard Therapeutics PLC ALLK Allakos GOSS Gossamer Bio MLNT Melinta Therapeutics PRVB Provention Bio SRPT Sarepta Therapeutics NBIX Neurocrine Biosciences ACAD ACADIA Pharmaceuticals LBPH Longboard Pharmaceuticals AXSM Axsome Therapeutics DNLI Denali Therapeutics HRMY Harmony Biosciences Holdings XENE Xenon Pharmaceuticals ALKS Alkermes Plc JAZZ Jazz Pharmaceuticals PLC PRAX Praxis Precision Medicines SAGE Sage Therapeutic SYRE Spyre Therapeutics APGE Apogee Therapeutics, Common Stock ATAI ATAI Life Sciences BV

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Mar-2021

$16

$-0.7 (-4.19%)

3 years 2 days ago
(05-Oct-2023)

1/3 (33.33%)

$0.05 (0.31%)

1

Buy Since 14-Sep-2020

$34

$17.3 (103.59%)

$34

3 years 1 months 28 days ago
(09-Aug-2023)

0/4 (0%)

$28.94 (571.94%)

Buy Since 29-Dec-2021

$15

$-1.7 (-10.18%)

$15

3 years 3 months 10 days ago
(27-Jun-2023)

3/3 (100%)

$9.77 (186.81%)

107

Buy Since 13-Mar-2023

$5

$-11.7 (-70.06%)

3 years 6 months 24 days ago
(13-Mar-2023)

1/1 (100%)

$0.05 (1.01%)

1

Buy Since 05-Sep-2019

$13

4 years 4 months 24 days ago
(13-May-2022)

2/2 (100%)

$-34.2 (-72.46%)

621

Show more analysts

Please expand the browser size to see the chart

Which stock is David Hoang most bullish on?

Potential upside of $93.86 has been obtained for PRAX (PRAXIS PRECISION MEDICINES)

Which stock is David Hoang most reserved on?

Potential downside of -$3.64 has been obtained for HRMY (HARMONY BIOSCIENCES HOLDINGS)

What Year was the first public recommendation made by David Hoang?

On 2018
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?